TKNO(Alpha Teknova, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $36.89M | $41.42M | $36.68M | $37.74M | $40.52M |
| 毛利润 | $17.62M | $17.48M | $10.30M | $7.23M | $13.44M |
| 营业利润 | −$12.01M | −$49.66M | −$35.56M | −$26.15M | −$16.98M |
| 净利润 | −$9.80M | −$47.47M | −$36.78M | −$26.75M | −$17.26M |
| 经营现金流 | −$9.07M | −$27.40M | −$18.81M | −$12.39M | −$8.65M |
| 自由现金流 | −$28.95M | −$55.55M | −$26.75M | −$13.52M | −$9.79M |
| 摊薄每股收益 | $-0.61 | $-1.69 | $-1.16 | $-0.57 | $-0.32 |